EP Patent

EP2701773B1 — Dose guides for injection syringe

Assigned to Icon Bioscience Inc · Expires 2019-02-27 · 7y expired

What this patent protects

Patent listed against Decadron.

Drugs covered by this patent

Decadron (dexamethasone) · Generic (originally Merck)

Patent Metadata

Patent number: EP2701773B1
Jurisdiction: EP
Classification: —
Expires: 2019-02-27
Drug substance claim: No
Drug product claim: No
Assignee: Icon Bioscience Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.